Live Breaking News & Updates on Pulmocide ltd

Stay informed with the latest breaking news from Pulmocide ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pulmocide ltd and stay connected to the pulse of your community

Aspergillosis Market Size is anticipated to increase during the study period, 2020–2034, estimates DelveInsight |

Aspergillosis Market Size is anticipated to increase during the study period, 2020–2034, estimates DelveInsight |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

Yashveer-bhardhwaj , Eli-lilly , Pulmocide-ltd , Abbott-laboratories , Johnson-services-inc , Pfizer-inc , Aspergillosis-companies , Astrazeneca , Scynexis-inc , Pfizer , Glaxosmithkline , Takeda-pharmaceutical-company-ltd

Global Invasive Fungal Infections Market Report 2023:

Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Global Invasive Fungal Infections Market: Analysis By Molecule Class, By Infection Type, By Region Size and...

Dublin , Ireland , United-states , American , America , Asia-pacific , Gilead-sciences-inc , Matinas-biopharma-holdings-inc , Pulmocide-ltd , Company-profiles , Merck-co-inc , Cidara-therapeutics-inc

Global Invasive Fungal Infections Market: Analysis By

Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep tissues, organs, or the...

New-york , United-states , America , American , Astellas-pharma , Asia-pacific , Merck-co-inc , Astellas-pharma-inc , Gilead-sciences-inc , Pfizer-inc , Pulmocide-ltd , Glaxosmithkline

Global Invasive Fungal Infections Market Report 2023: Sector to Reach $9 Billion by 2028 at a 3.96% CAGR

/PRNewswire/ -- The "Global Invasive Fungal Infections Market: Analysis By Molecule Class, By Infection Type, By Region Size and Trends with Impact of COVID-19...

Dublin , Ireland , United-states , America , American , Asia-pacific , Laura-wood , Matinas-biopharma-holdings-inc , Gilead-sciences-inc , Glaxosmithkline , Novo-nordiskas-xellia-pharmaceuticals , Office-hours-call

Investegate |Jeito Capital Announcements | Jeito Capital: Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing

Investegate announcements from Jeito Capital, Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing

United-states , Paris , France-general- , France , United-kingdom , Assia-mouhout , Daniel-burgess , Sabine-dandiguian , Asahi-kasei-pharma , Marion-bougeard , Sv-health-investors , Twitter

Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole

Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole - read this article along with other careers information, tips and advice on BioSpace

New-york , United-states , Milan , Lombardia , Italy , Tokyo , Japan , Dubai , Dubayy , United-arab-emirates , Shanghai , China

Pulmocide's lead drug candidate opelconazole (PC945) granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA

Pulmocide's lead drug candidate opelconazole (PC945) granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom , London , City-of , Daniel-burgess , Lucie-foster , Kostenloser-wertpapierhandel , Lindsey-neville , Jennifer-cayer , Sukaina-virji , Drug-administration , Pulmocide-ltd , Consilium-strategic-communications

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

United-states , Paris , France-general , France , Sabine-dandiguian , Dan-burgess , Asahi-kasei-pharma , Partnerat-jeito , Linkedin , Sv-health-investors , Pulmocide-ltd , Consilium-strategic-communications

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide | Comunicados | Edición USA

About Jeito Capital
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients’ access in Europe & the United States. Jeito Capital is based in Paris with a presence in Europe and the United States. For more information, please visit www.jeito.life, or follow on Twitter @Jeito_life or LinkedIn.
About Pulmocide
Pulmocide Ltd (www.pulmocide.com) is a late-stage biopharmaceutical company developing novel therapies for patients suffering from serious acute and chronic respiratory diseases. Pulmocide’s lead product is PC945, a novel antifungal specifically designed for inhaled use to maximize the amount of drug in the lung and spare systemic exposure. This is expected to provide for superior efficacy against respiratory Aspergillosis while minimizing systemic toxicities. PC945 is expected to be useful in a variety of conditions where Aspergillus has been implicated.

United-states , Paris , France-general , France , Sabine-dandiguian , Dan-burgess , Asahi-kasei-pharma , Partnerat-jeito , Linkedin , Sv-health-investors , Pulmocide-ltd , Consilium-strategic-communications

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Japan , Tokyo , Paris , France-general , France , United-kingdom , Boston , Massachusetts , Zurich , Züsz